By Robert Preidt
FRIDAY, Feb. 12, 2021 (HealthDay Information) — Giving blood thinners to COVID-19 sufferers quickly after they’re hospitalized may cut back their threat of dying.
That is the conclusion of a brand new examine that analyzed information from the U.S. Division of Veterans Affairs on practically 4,300 sufferers, common age 68, who have been hospitalized with COVID between March 1 and July 31.
Of these, greater than 84% acquired blood thinners inside 24 hours of admission — a step referred to as prophylactic anticoagulation.
Within the 30 days after admission, the general loss of life charge was 14.5%.
The loss of life charge was 14.3% amongst sufferers who acquired the blood thinners and 18.7% amongst those that didn’t.
The profit seemed to be higher amongst sufferers who weren’t admitted to intensive care inside 24 hours of hospitalization.
Researchers stated they accounted for different probably essential components akin to sufferers’ age, ethnicity, underlying well being situations, remedy historical past, weight and tobacco use.
Considerably, sufferers who acquired blood thinners did not have a better threat of great bleeding than those that did not obtain blood thinners, in keeping with the staff led by Christopher Rentsch, an assistant professor at London College of Hygiene and Tropical Medication in England. The findings have been revealed Feb. 11 within the BMJ.
Clinical trials are being performed to find out if prophylactic anticoagulation may very well be an efficient therapy for COVID-19.
Till outcomes from these trials can be found, this examine’s findings “present robust actual world proof to assist pointers recommending the usage of prophylactic anticoagulation as preliminary therapy for sufferers with COVID-19 on hospital admission,” Rentsch and his colleagues stated in a journal information launch.
The U.S. Facilities for Illness Management and Prevention has extra on COVID-19.
SOURCE: BMJ, information launch, Feb. 11, 2021